PerioTrap Pharmaceuticals GmbH
Haale
About PerioTrap Pharmaceuticals GmbH
PerioTrap is an inflammation of the gums mainly caused by a microbiome shift towards pathogenic bacteria. They develop an anti-infective drug that is capable of targeting the disease-causing pathogens and represents an alternative to classic broad-spectrum antibiotics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.1M
- Funding stage: Seed
- Last round: Seed (Jan 2025)
- Website: periotrap.com
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/periotrap-pharmaceuticals-gmbh-90271 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.